Topic
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
10 Podcasts • 1 Course on BackTable
Hear how experienced physicians manage Metastatic Castration-Resistant Prostate Cancer (mCRPC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 332 • 29 Sept 2026
The Basics of Advanced Prostate Cancer Management for Urologists
What does a urologist actually need to know to confidently manage advanced prostate cancer in the clinic? On this episode of BackTable Urology, host Dr. Ruchika Talwar interviews Dr. Kristen Scarpato, director of the advanced prostate cancer clinic at Vanderbilt University Medical Center, and Dr. Jason Hafron, chief medical officer of the Michigan Institute of Urology. They break down how the landscape has shifted, why more patients stay in urology for treatment, and how to select and monitor therapy based on disease state, comorbidities, and patient goals.
This podcast is supported by
More on Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Loading recent podcasts…
Urology # 332
Sep 28, 2026
with Dr. Kristen Scarpato, Dr. Jason Hafron
What does a urologist actually need to know to confidently manage advanced prostate cancer in the clinic? On this...
Urology # 314
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
1,000+ listens
Urology # 303
May 18, 2026
with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...
1,300+ listens
Urology # 259
Sep 8, 2025
with Dr. Parth Modi, Dr. Neeraj Agarwal, Dr. Tyler Seibert
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of...
2,000+ listens
Tumor Board # 71
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Urology # 307
Jun 8, 2026
with Dr. Tanya Dorff, Dr. Evan Yu, Dr. Alan Tan
Can you really treat prostate cancer effectively without knowing the genetics? In this episode of BackTable Urology,...
1,000+ listens
Tumor Board # 60
May 18, 2026
with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan
Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...
Tumor Board # 21
Aug 18, 2025
with Dr. Parth Modi, Dr. Neeraj Agarwal, Dr. Tyler Seibert
Could ongoing trials redefine the management of oligometastatic and advanced prostate cancer? In this installment of...
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.